Solara Active Pharma Sciences Ltd Partly Paidup
₹
None%
- close price
About
[
edit about
]
[
add key points
]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 16 May
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
15 May - Q4 FY25 earnings call audio uploaded on Solara's website for investor access.
-
Appointment Of Internal Auditors Secretarial Auditor And Reappointment Of Cost Auditor.
15 May - Approved FY25 audited results; allotted 1 lakh ESOP shares; new Company Secretary appointed; auditor appointments made.
-
Announcement under Regulation 30 (LODR)-Retirement
15 May - Approved FY25 audited results, ESOP allotment of 1 lakh shares, KMP change, auditor appointments.
-
Appointment of Company Secretary and Compliance Officer
15 May - Approved FY25 audited results, allotted 1L ESOP shares at Rs.252, appointed new company secretary and auditors.
Annual reports
No data available.